You just read:

Compass Biotechnologies Inc (COBI: OB) announces its subsidiary company C-Pharma to focus on Hepatitis Franchise while Compass focuses on Biosimiliar and Bio-Better near term revenue products

News provided by

Cyplasin Biomedical Ltd.

Apr 08, 2011, 04:17 ET